Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × darolutamide × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Biochemically Recurrent Prostate Cancer 2 Urogenital Neoplasms 1 Urogenital Diseases 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Non-metastatic Castration-resistant Prostate Cancer 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Male Urogenital Diseases 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

pembrolizumab 73 Carboplatin 63 Pemetrexed 54 Cisplatin 40 Paclitaxel 35 durvalumab 23 Specimen Handling 23 Nivolumab 19 Magnetic Resonance Spectroscopy 18 Gemcitabine 17 osimertinib 14 Docetaxel 14 Bevacizumab 13 130-nm albumin-bound paclitaxel 12 atezolizumab 11 Cetuximab 10 cemiplimab 9 Taxes 9 Radiotherapy 9 Immunoglobulin G 9 Drug Therapy 9 Radiosurgery 8 Disulfides 8 Biopsy 8 tislelizumab 7 amivantamab 7 Observation 7 Fluorouracil 7 Oxaliplatin 6 Leucovorin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡